Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 14, 2025 • 11:01 PM ET

Date/Time Source News Release
08/12/2025 04:00 PM EDT GlobeNewswire Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer's Disease
08/07/2025 04:00 PM EDT GlobeNewswire Cognition Therapeutics Reports Financial Results for the Second Quarter 2025 and Highlights Progress Across Clinical Programs
07/29/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer's Disease
07/21/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesine's Protection of Neurons and Synapses in Alzheimer's Disease
07/16/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics' Positive Clinical Data from Zervimesine (CT1812) Phase 2 Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC
07/10/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer's Disease
07/01/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer's Disease Surpasses 50% Enrollment Target
06/25/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer's Disease and Dementia with Lewy Bodies (DLB)
06/03/2025 07:30 AM EDT GlobeNewswire Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
05/28/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
Page

Additional News

As of August 14, 2025 • 11:01 PM ET

Date/Time Source News Release
08/13/2025 11:22 AM EDT 24/7 Market News Morning Market Brief with a Trade This, Not That, as Kraig Labs Spins a Stronger Web
08/13/2025 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Aug 13, 2025 as of 10.00 am ET
08/09/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cognition Therapeutics Inc.
08/07/2025 05:28 PM EDT SeekingAlpha Cognition Therapeutics GAAP EPS of -$0.11 misses by $0.01
07/10/2025 03:29 PM EDT SeekingAlpha Cognition soars 35% after positive FDA meeting on Alzheimer's asset zervimesine
07/10/2025 12:31 PM EDT PRISM News Cognition Therapeutics Wraps Up FDA Review, Moves Closer to Phase 3 Alzheimer's Trial
07/10/2025 08:36 AM EDT 24/7 Market News Cognition Therapeutics Receives Positive Feedback on Registrational Pathway during End-of-Phase 2 FDA Meeting for Zervimesine (CT1812) in Alzheimer's Disease
05/08/2025 11:33 AM EDT SeekingAlpha Cognition Therapeutics GAAP EPS of -$0.14 misses by $0.04
05/06/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 6th, 2025
05/06/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cognition Therapeutics Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.